Elicio Therapeutics Inc
Research Elicio Therapeutics Inc (ELTX) on Bullrun: market cap USD 76.34M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerELTX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 76.34M
- Financial periodFY2025
- Net income-USD 39.57M
- Free cash flow-USD 36.97M
Valuation Snapshot
latest market cap is USD 76.34M.
About Elicio Therapeutics Inc
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trials for seven Kirsten rat sarcoma viral oncogene homolog driver mutations.
Frequently asked questions
What is Elicio Therapeutics Inc's market cap?
Elicio Therapeutics Inc's market capitalization is USD 76.34M.
What does Elicio Therapeutics Inc do?
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trials for seven Kirsten rat sarcoma viral...